Form 4: Tenet Healthcare CEO Awarded 52,065 Restricted Stock Units

Tenet Healthcare's CEO, Saumya Sutaria, was granted 52,065 restricted stock units that vest annually over four years.

Summary

• Saumya Sutaria, the Chairman and CEO of Tenet Healthcare Corp, was granted 52,065 restricted stock units on January 23, 2025.
• These restricted stock units will vest in four equal annual installments starting on December 31, 2025, and continuing through 2028.
• The units are based on common stock and have a price of $0 at the time of grant.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications.

Positives

• The grant of restricted stock units aligns the CEO's interests with the long-term performance of the company.
• The vesting schedule encourages the CEO's continued service and contribution to the company over the next four years.

Future Outlook

The restricted stock units will vest over the next four years, incentivizing the CEO to focus on long-term value creation.

Industry Context

Stock-based compensation is a common practice for aligning executive interests with shareholder value in the healthcare industry.

Comparison to Industry Standards

• Many healthcare companies use restricted stock units as part of their executive compensation packages.
• The vesting schedule of four years is a typical timeframe for such grants.
• Companies like HCA Healthcare and Universal Health Services also use similar equity-based compensation strategies.

Stakeholder Impact

• Shareholders may view this as a positive sign of aligning management with long-term company performance.
• Employees may see this as a sign of stability and commitment from the leadership.

Key Dates

Keywords

restricted stock units, stock grant, executive compensation, Tenet Healthcare, Saumya Sutaria, equity